Clinical Trial Update: Evaluation in STEMI Patients Using FDY-5301 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating FDY-5301 in patients with ST-segment elevation myocardial infarction has completed enrollment and the study is finished, foc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• FDY-5301

Snippet

Sponsor: Faraday Pharmaceuticals, Inc. | Conditions: Acute Myocardial Infarction, STEMI | Phase 3 | Status: COMPLETED